Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients - CRCL-Ciblage thérapeutique de la tumeur et de son environnement immunitaire Accéder directement au contenu
Article Dans Une Revue International Journal of Cancer Année : 2022

Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients

Résumé

Beyond their critical role in hemostasis, platelets physically interact with neutrophils to form neutrophil-platelet aggregates (NPAs), enhancing neutrophil effector functions during inflammation. NPAs may also promote disease worsening in various inflammatory diseases. However, characterization of NPAs in cancer remains totally unexplored. Using ImageStreamX (ISX) imaging flow cytometer, we were not only allowed able to detect CD15+ CD14- CD36+ ITGA2B+ NPAs in both healthy donors' (HDs) and cancer patients' bloods, but we also showed that NPAs result from the binding of platelets preferentially to low-density neutrophils (LDNs) as opposed to normal-density neutrophils (NDNs). By reanalyzing two independent public scRNAseq data of whole blood leukocytes from cancer patients and HDs, we could identify a subset of neutrophils with high platelet gene expression that may correspond to NPAs. Moreover, we showed that cancer patients' derived NPAs possessed a distinct molecular signature compared to the other neutrophil subsets, independently of platelet genes. Gene ontology (GO) term enrichment analysis of this NPAs-associated neutrophil transcriptomic signature revealed a significant enrichment of neutrophil degranulation, chemotaxis and trans-endothelial migration GO terms. Lastly, using The Cancer Genome Atlas (TCGA), we could show by multivariate Cox analysis that the NPAs-associated neutrophil transcriptomic signature was associated with a worse patient prognosis in several cancer types. These results suggest that neutrophils from NPAs are systemically primed by platelets empowering them with cancer progression capacities once at tumor site. NPAs may therefore hold clinical utility as novel noninvasive blood prognostic biomarker in cancer patients with solid tumors.

Domaines

Immunologie
Fichier principal
Vignette du fichier
IJC-151-138.pdf (6.35 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03769720 , version 1 (22-06-2023)

Identifiants

Citer

Pacôme Lecot, Maude Ardin, Sébastien Dussurgey, Vincent Alcazer, Lyvia Moudombi, et al.. Gene signature of circulating platelet‐bound neutrophils is associated with poor prognosis in cancer patients. International Journal of Cancer, 2022, 151 (1), pp.138-152. ⟨10.1002/ijc.33991⟩. ⟨hal-03769720⟩
40 Consultations
11 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More